Silverfin false false 31/12/2024 01/01/2024 31/12/2024 Dr J R Glover 17/11/2009 19 November 2025 no description of principal activity 07058709 2024-12-31 07058709 bus:Director1 2024-12-31 07058709 2023-12-31 07058709 core:CurrentFinancialInstruments 2024-12-31 07058709 core:CurrentFinancialInstruments 2023-12-31 07058709 core:ShareCapital 2024-12-31 07058709 core:ShareCapital 2023-12-31 07058709 core:RetainedEarningsAccumulatedLosses 2024-12-31 07058709 core:RetainedEarningsAccumulatedLosses 2023-12-31 07058709 core:Vehicles 2023-12-31 07058709 core:OfficeEquipment 2023-12-31 07058709 core:Vehicles 2024-12-31 07058709 core:OfficeEquipment 2024-12-31 07058709 core:CostValuation 2023-12-31 07058709 core:AdditionsToInvestments 2024-12-31 07058709 core:RevaluationsIncreaseDecreaseInInvestments 2024-12-31 07058709 core:CostValuation 2024-12-31 07058709 2022-12-31 07058709 core:AcceleratedTaxDepreciationDeferredTax 2024-12-31 07058709 core:AcceleratedTaxDepreciationDeferredTax 2023-12-31 07058709 core:FurtherSpecificItem1DeferredTaxComponentTotalForDeferredTax 2024-12-31 07058709 core:FurtherSpecificItem1DeferredTaxComponentTotalForDeferredTax 2023-12-31 07058709 2024-01-01 2024-12-31 07058709 bus:FilletedAccounts 2024-01-01 2024-12-31 07058709 bus:SmallEntities 2024-01-01 2024-12-31 07058709 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 07058709 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 07058709 bus:Director1 2024-01-01 2024-12-31 07058709 core:Vehicles 2024-01-01 2024-12-31 07058709 core:OfficeEquipment core:TopRangeValue 2024-01-01 2024-12-31 07058709 2023-01-01 2023-12-31 07058709 core:OfficeEquipment 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure

Company No: 07058709 (England and Wales)

DR J R GLOVER RADIOLOGY LTD

Unaudited Financial Statements
For the financial year ended 31 December 2024
Pages for filing with the registrar

DR J R GLOVER RADIOLOGY LTD

Unaudited Financial Statements

For the financial year ended 31 December 2024

Contents

DR J R GLOVER RADIOLOGY LTD

COMPANY INFORMATION

For the financial year ended 31 December 2024
DR J R GLOVER RADIOLOGY LTD

COMPANY INFORMATION (continued)

For the financial year ended 31 December 2024
DIRECTOR Dr J R Glover
REGISTERED OFFICE Onslow House
Onslow Street
Guildford
Surrey
GU1 4TL
United Kingdom
COMPANY NUMBER 07058709 (England and Wales)
ACCOUNTANT S&W Partners LLP
Onslow House
Onslow Street
Guildford
GU1 4TL
DR J R GLOVER RADIOLOGY LTD

BALANCE SHEET

As at 31 December 2024
DR J R GLOVER RADIOLOGY LTD

BALANCE SHEET (continued)

As at 31 December 2024
Note 2024 2023
£ £
Fixed assets
Tangible assets 4 22,946 30,595
Investments 5 506,535 475,627
529,481 506,222
Current assets
Debtors 6 14,460 6,831
Cash at bank and in hand 21,123 20,730
35,583 27,561
Creditors: amounts falling due within one year 7 ( 61,742) ( 58,108)
Net current liabilities (26,159) (30,547)
Total assets less current liabilities 503,322 475,675
Provision for liabilities 8 ( 16,467) ( 18,380)
Net assets 486,855 457,295
Capital and reserves
Called-up share capital 40 40
Profit and loss account 486,815 457,255
Total shareholders' funds 486,855 457,295

For the financial year ending 31 December 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of Dr J R Glover Radiology Ltd (registered number: 07058709) were approved and authorised for issue by the Director on 19 November 2025. They were signed on its behalf by:

Dr J R Glover
Director
DR J R GLOVER RADIOLOGY LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2024
DR J R GLOVER RADIOLOGY LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Dr J R Glover Radiology Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Onslow House, Onslow Street, Guildford, Surrey, GU1 4TL, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with ‘The Financial Reporting Standard applicable in the UK and the Republic of Ireland’ issued by the Financial Reporting Council, including Section 1A of Financial Reporting Standard 102 (FRS102), and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The functional currency of Dr J R Glover Radiology Ltd is considered to be pounds sterling because that is the currency of the primary economic environment in which the Company operates.

These financial statements are separate financial statements.

Going concern

The financial statements have been prepared on a going concern basis.

The director has made an assessment in preparing these financial statements as to whether the Company is a going concern and have concluded that there are no material uncertainties that may cast significant doubt on the Company's ability to continue as a going concern for a period of at least 12 months from the date of approval of these financial statements.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Turnover from the supply of services represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the fair value of the consideration received or receivable. Where a contract has only been partially completed at the Balance Sheet date turnover represents the fair value of the service provided to date based on the stage of completion of the contract activity at the Balance Sheet date. Where payments are received from customers in advance of services provided, the amounts are recorded as deferred income and included as part of creditors due within one year.

Employee benefits

Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Profit and Loss Account in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Balance Sheet.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on enacted or substantively enacted tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit. Deferred tax assets are recognised only to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilised.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Vehicles 25 % reducing balance
Office equipment 3 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Fixed asset investments

Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers.

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Provisions

Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Balance Sheet date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).

When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders.

2. Critical accounting judgements and key sources of estimation uncertainty

In the application of the Company’s accounting policies, the director is required to make judgements that have a significant impact on the amounts recognised. The following are the critical judgements that the director has made in the process of applying the Company’s accounting policies and that have the most significant effect on the amounts recognised in the financial statements.

3. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including the director 2 2

4. Tangible assets

Vehicles Office equipment Total
£ £ £
Cost
At 01 January 2024 40,794 2,876 43,670
At 31 December 2024 40,794 2,876 43,670
Accumulated depreciation
At 01 January 2024 10,199 2,876 13,075
Charge for the financial year 7,649 0 7,649
At 31 December 2024 17,848 2,876 20,724
Net book value
At 31 December 2024 22,946 0 22,946
At 31 December 2023 30,595 0 30,595

5. Fixed asset investments

Listed investments Other investments Total
£ £ £
Cost or valuation before impairment
At 01 January 2024 474,627 1,000 475,627
Additions 40,000 0 40,000
Movement in fair value ( 9,092) 0 ( 9,092)
At 31 December 2024 505,535 1,000 506,535
Carrying value at 31 December 2024 505,535 1,000 506,535
Carrying value at 31 December 2023 474,627 1,000 475,627

6. Debtors

2024 2023
£ £
Trade debtors 12,508 4,664
Prepayments 1,952 2,167
14,460 6,831

7. Creditors: amounts falling due within one year

2024 2023
£ £
Trade creditors 9,498 5,744
Amounts owed to director 31,128 31,128
Accruals 9,493 6,319
Taxation and social security 11,623 12,191
Other creditors 0 2,726
61,742 58,108

8. Deferred tax

2024 2023
£ £
At the beginning of financial year ( 18,380) ( 15,961)
Credited/(charged) to the Profit and Loss Account 1,913 ( 2,419)
At the end of financial year ( 16,467) ( 18,380)

The deferred taxation balance is made up as follows:

2024 2023
£ £
Accelerated capital allowances ( 5,737) ( 7,649)
Capital gains ( 10,730) ( 10,731)
( 16,467) ( 18,380)

9. Financial commitments

Other financial commitments

2024 2023
£ £
The company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund 40,000 40,000

As at the year end the amount due to the pension scheme is £nil.

10. Related party transactions

Transactions with the entity's director

2024 2023
£ £
Directors loan 31,128 31,128

Included in other creditors is an interest free loan of £31,128 (2023 - £31,128), which is repayable on demand and represents the goodwill acquired by the company from Dr J R Glover on incorporation, plus expenses paid by the director on behalf of the company.